Anti-CREB3 antibody [EPR14215(B)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal CREB3 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications.
View Alternative Names
LZIP, CREB3, Cyclic AMP-responsive element-binding protein 3, CREB-3, cAMP-responsive element-binding protein 3, Leucine zipper protein, Luman, Transcription factor LZIP-alpha
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CREB3 antibody [EPR14215(B)] (AB180119)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 293 cells labeling CREB3 with ab180119 at 1/100 dilution. Counterstained with DAPI (blue).
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CREB3 antibody [EPR14215(B)] (AB180119)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed HeLa cellslabeling CREB3 with ab180119 at 1/100 dilution (red) compared toa rabbit IgGcontrol (green), followed by secondaryGoat anti rabbit IgG (FITC) at 1/75 dilution.
- WB
Supplier Data
Western blot - Anti-CREB3 antibody [EPR14215(B)] (AB180119)
All lanes:
Western blot - Anti-CREB3 antibody [EPR14215(B)] (ab180119) at 1/10000 dilution
Lane 1:
HepG2 cell lysate at 20 µg
Lane 2:
293 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 44 kDa
Observed band size: 40 kDa
false
- WB
Supplier Data
Western blot - Anti-CREB3 antibody [EPR14215(B)] (AB180119)
All lanes:
Western blot - Anti-CREB3 antibody [EPR14215(B)] (ab180119) at 1/2000 dilution
All lanes:
HeLa cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 44 kDa
Observed band size: 40 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CREB3 activates transcription by binding to cyclic AMP-responsive elements (CRE) in the promoters of target genes. It forms part of a wider regulatory network and can interact with other transcription factors to modulate gene expression. This protein is involved in the unfolded protein response which is essential for maintaining cellular homeostasis particularly under stress conditions.
Pathways
CREB3 plays an important role in the endoplasmic reticulum stress response pathway. It helps in the regulation of genes involved in protein folding and secretion. CREB3 also interacts with other proteins such as ATF6 which operates in similar pathways to coordinate cell survival and adaptation mechanisms under stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39:e70919 PubMed40772309
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 14:2874-2884 PubMed40530130
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 301:108247 PubMed39894218
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 20:e1012748 PubMed39652582
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e18373 PubMed38894657
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 44:101684 PubMed38641372
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:4494 PubMed35918380
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 24:233 PubMed35720482
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gastrointestinal oncology 11:1186-1199 PubMed33456992
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 20:524-536 PubMed30395767
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com